Changes in symptoms and characteristics of COVID-19 patients … – BMC Infectious Diseases

Scovino AM, Dahab EC, Vieira GF, Freire-de-Lima L, Freire-de-Lima CG, Morrot A. SARS-CoV-2s Variants of Concern: A Brief Characterization. Front Immunol. 2022;13:834098.

Coronaviridae Study Group of the International Committee on Taxonomy of V. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):53644.

Article Google Scholar

WHO. Naming the coronavirus disease (COVID-19) and the virus that causes it. In: World Health Organisation. 2020.

Google Scholar

Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). 2020. https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov).

WHO Director-General's remarks at the Member State Briefing on the report of the international team studying the origins of SARS-CoV-2. 2021.https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-member-state-briefing-on-the-report-of-the-international-team-studying-the-origins-of-sars-cov-2.

Tracking SARS-CoV-2 variants.https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/.

WHO. World Health Organization,Coronavirus disease (COVID-19): variants of SARS-COV-2. World Health Organization. 2021.

Google Scholar

Peyrony O, Marbeuf-Gueye C, Truong V, Giroud M, Rivire C, Khenissi K, Legay L, Simonetta M, Elezi A, Principe A. Accuracy of emergency department clinical findings for diagnosis of coronavirus disease 2019. Ann Emerg Med. 2020;76(4):40512.

Article PubMed PubMed Central Google Scholar

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):50713.

Article CAS Google Scholar

Prevention TCoDCa. Symptoms of COVID-19. 2022.

Google Scholar

Hawkes CH. Smell, taste and COVID-19: testing is essential. QJM. 2020;114(2):8391.

Article Google Scholar

Bager P, Wohlfahrt J, Bhatt S, Stegger M, Legarth R, Mller CH, Skov RL, Valentiner-Branth P, Voldstedlund M, Fischer TK, et al. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study. Lancet Infect Dis. 2022;22(7):96776.

Article CAS PubMed PubMed Central Google Scholar

Sumner MW, Xie J, Zemek R, Winston K, Freire G, Burstein B, Kam A, Emsley J, Gravel J, Porter R. Comparison of Symptoms Associated With SARS-CoV-2 Variants Among Children in Canada. JAMA Netw Open. 2023;6(3):e232328.

Article PubMed PubMed Central Google Scholar

Miyashita K, Hozumi H, Furuhashi K, Nakatani E, Inoue Y, Yasui H, Karayama M, Suzuki Y, Fujisawa T, Enomoto N. Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study. Emerg Microbes Infect. 2023;12(1):e2155250.

Article Google Scholar

Schulze H, Bayer W. Changes in symptoms experienced by SARS-Cov-2-infected individualsfrom the first wave to the Omicron variant. Front Virol. 2022;2:880707.

Whitaker M, Elliott J, Bodinier B, Barclay W, Ward H, Cooke G, Donnelly CA, Chadeau-Hyam M, Elliott P. Variant-specific symptoms of COVID-19 among 1,542,510 people in England. medRxiv. 2022:2022.05.

Roser HRaEMaLR-GaCAaCGaEO-OaJHaBMaDBaM: Coronavirus Pandemic (COVID-19). Our World in Data 2020. https://ourworldindata.org/covid-vaccinations?country=SYR.

Gangavarapu K, Latif AA, Mullen JL, Alkuzweny M, Hufbauer E, Tsueng G, Haag E, Zeller M, Aceves CM, Zaiets K, et al. Outbreak info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations. Nat Methods. 2023;20(4):51222.

Article CAS PubMed PubMed Central Google Scholar

Centers for Disease Control and Prevention. Screening Clients for COVID-19 at Homeless Shelters or Encampments. 2020.

Hosmer Jr DW, Lemeshow S, Sturdivant RX. Applied logistic regression, vol. 398. New Jersey: Wiley; 2013.

Kianfar N, Mesgari MS, Mollalo A, Kaveh M. Spatio-temporal modeling of COVID-19 prevalence and mortality using artificial neural network algorithms. Spatial Spatio-temporal Epidemiol. 2022;40:100471.

Article Google Scholar

Cybenko G. Approximation by superpositions of a sigmoidal function. Math Control Signals Systems. 1989;2(4):30314.

Article Google Scholar

Williams G. Data mining with Rattle and R: The art of excavating data for knowledge discovery. New York: Springer Science & Business Media; 2011.

Book Google Scholar

Hesni E, Sayad B, Khosravi Shadmani F, Najafi F, Khodarahmi R, Rahimi Z, Bozorgomid A, Sayad N. Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study. BMC Infect Dis. 2022;22(1):112.

Article Google Scholar

Mousavi SF, Ebrahimi M, Moghaddam SA, Moafi N, Jafari M, Tavakolian A, Heidary M. Evaluating the characteristics of patients with SARS-CoV-2 infection admitted during COVID-19 peaks: A single-center study. Vacunas. 2022;24(1):2736.

Godbout A, Drolet M, Mondor M, Simard M, Sauvageau C, De Serres G, Brisson M. Time trends in social contacts of individuals according to comorbidity and vaccination status, before and during the COVID-19 pandemic. BMC Med. 2022;20(1):114.

Article Google Scholar

Wambua J, Hermans L, Coletti P, Verelst F, Willem L, Jarvis CI, Gimma A, Wong KL, Lajot A, Demarest S. The influence of risk perceptions on close contact frequency during the SARS-CoV-2 pandemic. Sci Rep. 2022;12(1):112.

Article Google Scholar

Roland LT, Gurrola JG, Loftus PA, Cheung SW, Chang JL. Smell and taste symptombased predictive model for COVID19 diagnosis. Int Forum Allergy Rhinol. 2020.10(7):8328.

Guntur VP, Modena BD, Manka LA, Eddy JJ, Liao S-Y, Goldstein NM, Zelarney P, Horn CA, Keith RC, Make BJ. Characteristics and outcomes of ambulatory patients with suspected COVID-19 at a respiratory referral center. Respir Med. 2022;197:106832.

Article PubMed PubMed Central Google Scholar

Sun Y, Koh V, Marimuthu K, Ng OT, Young B, Vasoo S, Chan M, Lee VJ, De PP, Barkham T. Epidemiological and clinical predictors of COVID-19. Clin Infect Dis. 2020;71(15):78692.

Chadeau-Hyam M, Bodinier B, Elliott J, Whitaker MD, Tzoulaki I, Vermeulen R, Kelly-Irving M, Delpierre C, Elliott P. Risk factors for positive and negative COVID-19 tests: a cautious and in-depth analysis of UK biobank data. Int J Epidemiol. 2020;49(5):145467.

Article PubMed Google Scholar

Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, Spijker R, Hooft L, Emperador D, Domen J, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst Rev. 2021;2:CD013665.

PubMed Google Scholar

Sabetian G, Moghadami M. Hashemizadeh Fard Haghighi L, Shahriarirad R, Fallahi MJ, Asmarian N, Moeini YS: COVID-19 infection among healthcare workers: a cross-sectional study in southwest Iran. Virol J. 2021;18(1):18.

Article Google Scholar

Alimohamadi Y, Sepandi M, Taghdir M, Hosamirudsari H. Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. J Prev Med Hyg. 2020;61(3):E30412.

PubMed PubMed Central Google Scholar

Goshayeshi L, Akbari Rad M, Bergquist R, Allahyari A, Hashemzadeh K, Milani N, Gholian-Aval M, Rezaeitalab F, Sadeghi Quchani MJ, Nahbandani Z, et al. Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences. Iran BMC Infect Dis. 2021;21(1):656.

Article CAS PubMed Google Scholar

Boehmer TK, DeVies J, Caruso E, van Santen KL, Tang S, Black CL, Hartnett KP, Kite-Powell A, Dietz S, Lozier M. Changing age distribution of the COVID-19 pandemicUnited States, MayAugust 2020. Morb Mortal Wkly Rep. 2020;69(39):1404.

Article CAS Google Scholar

Feehan AK, Fort D, Velasco C, Burton JH, Garcia-Diaz J, Price-Haywood EG, Sapp E, Pevey D, Seoane L. The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study. Clin Microbiol Infect. 2021;27(4):633 e639-633 e616.

Article Google Scholar

Song Y, Ge Z, Cui S, Tian D, Wan G, Zhu S, Wang X, Wang Y, Zhao X, Xiang P. COVID-19 cases from the first local outbreak of the SARS-CoV-2 B. 1.1. 7 variant in China may present more serious clinical features: a prospective, comparative cohort study. Microbiol Spectrum. 2021;9(1):e00273-00221.

Article CAS Google Scholar

Petretto DR, Pili R. Ageing and COVID-19: What Is the Role for Elderly People? Geriatrics. 2020;5(2):25.

Article PubMed PubMed Central Google Scholar

Vaira LA, De Riu G, editors. Reader response: Loss of smell in COVID-19 patients. MRI data reveals a transient edema of the olfactory clefts. 2021.

Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):15.

Sungnak W, Huang N, Bcavin C, Berg M, Queen R, Litvinukova M, Talavera-Lpez C, Maatz H, Reichart D, Sampaziotis F. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):6817.

Article CAS PubMed PubMed Central Google Scholar

Vihta KD, Pouwels KB, Peto TE, Pritchard E, Eyre DW, House T, Gethings O, Studley R, Rourke E, Cook D. Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom. Clin Infect Dis. 2022;75(1):e32937.

Article PubMed Google Scholar

Vihta KD, Pouwels KB, Peto TE, Pritchard E, House T, Studley R, Rourke E, Cook D, Diamond I, Crook D, Clifton DA. Omicron-associated changes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) symptoms in the United Kingdom. Clin Infect Dis. 2023;76(3):e13341.

Cojocaru C, Cojocaru E, Turcanu AM, Zaharia DC. Clinical challenges of SARS-CoV-2 variants. Exp Ther Med. 2022;23(6):19.

Article Google Scholar

Elliott J, Whitaker M, Bodinier B, Eales O, Riley S, Ward H, Cooke G, Darzi A, Chadeau-Hyam M, Elliott P. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people. PLoS Med. 2021;18(9):e1003777.

Article CAS PubMed PubMed Central Google Scholar

Marquez C, Kerkhoff AD, Schrom J, Rojas S, Black D, Mitchell A, Wang C-Y, Pilarowski G, Ribeiro S, Jones D. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA. 1 Periods. JAMA Network Open. 2022;5(10):e2235844e2235844.

Article PubMed PubMed Central Google Scholar

Ekroth AK, Patrzylas P, Turner C, Hughes GJ, Anderson C. Comparative symptomatology of infection with SARS-CoV-2 variants Omicron (B. 1.1. 529) and Delta (B. 1.617. 2) from routine contact tracing data in England. Epidemiol Infect. 2022;150:e162.

Article PubMed Google Scholar

Lippi G, Nocini R, Henry BM. Analysis of online search trends suggests that SARS-CoV-2 Omicron (B. 1.1. 529) variant causes different symptoms. J Infect. 2022;84(5):e767.

Article CAS PubMed PubMed Central Google Scholar

Arora S, Grover V, Saluja P, Algarni YA, Saquib SA, Asif SM, Batra K, Alshahrani MY, Das G, Jain R. Literature review of omicron: a grim reality amidst COVID-19. Microorganisms. 2022;10(2):451.

Article CAS PubMed PubMed Central Google Scholar

Xu X-W, Wu X-X, Jiang X-G, Xu K-J, Ying L-J, Ma C-L, Li S-B, Wang H-Y, Zhang S, Gao H-N: Clinical findings in a group of patients infected with the,. novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2019;2020:368.

Google Scholar

Modes ME, Directo MP, Melgar M, Johnson LR, Yang H, Chaudhary P, Bartolini S, Kho N, Noble PW, Isonaka S. Clinical characteristics and outcomes among adults hospitalized with laboratory-confirmed SARS-CoV-2 infection during periods of B. 1.617. 2 (Delta) and B. 1.1. 529 (Omicron) variant predominanceone hospital, California, July 15September 23, 2021, and December 21, 2021January 27, 2022. Morb Mortal Wkly Rep. 2022;71(6):21723.

Article CAS Google Scholar

Ettaboina SK, Nakkala K, Laddha K. A mini review on SARS-COVID-192 omicron variant (B. 1.1. 529). Sci Med J. 2021;3(4):399406.

CAS Google Scholar

Read the original:

Changes in symptoms and characteristics of COVID-19 patients ... - BMC Infectious Diseases

Related Posts
Tags: